Medical Innovation

ROCHESTER, Minn. — Mayo Clinic will launch a new Mayo Clinic Proceedings expansion journal on digital health, with the first issue to be published in ...

Nucleus RadioPharma is developing technologies to usher in a new era in radiopharmaceutical development, supply chain and manufacturing ROCHESTER, Minn., and PALO ALTO, Calif. — Eclipse, ...

Vaccines have protected people from deadly diseases for generations. Could they also help fight cancer?   Mayo Clinic researchers are working to develop personalized therapeutic cancer vaccines ...

ROCHESTER, Minn. — An important new clue for preventing and treating brain tumors known as gliomas has been identified in research led by the Lunenfeld-Tannenbaum ...

In a new study published in Nature Medicine, Mayo Clinic and several research collaborators from across the U.S., describe a successful new artificial intelligence, or ...

ROCHESTER, Minn. — Mayo Clinic researchers have discovered that people with major depressive disorder and a history of attempted suicide have distinct biomarkers that correlate ...

Somatic mutations naturally occur in cells throughout human development and during aging. However, it has yet to be determined whether the frequency of somatic mutations ...

An AI-guided targeted screening strategy is effective in detecting new cases of atrial fibrillation that would not have come to attention in routine clinical care. This ...

Through research, clinical trials and biomanufacturing, Mayo Clinic’s Center for Regenerative Biotherapeutics is working to develop new types of medicines derived from the human body ...

Integrative medicine combines conventional Western medicine with complementary and alternative treatments that have been researched and proven to be safe and effective in healing. Integrative ...

ROCHESTER, Minn. — Researchers at Mayo Clinic Comprehensive Cancer Center have identified a gene marker that may lead to a more effective, precision treatment for pancreatic ductal adenocarcinoma ...

ROCHESTER, Minn. — In a new study published in Molecular Cancer Research, Mayo Clinic researchers identified critical genomic changes in response to abiraterone acetate/prednisone, a ...